Neuropathology of Amnestic Mild Cognitive Impairment

Emerging Concepts in Alzheimer's Disease

“…Braak stage III and IV AD neuropathologic change was most commonly encountered, but two (of fifteen) patients in one study had neocortical pathologic abnormalities (Braak stage V). Over half of the patients who came to necropsy had evidence of significant CVD, including hippocampal injury that was often interpreted as ischemic in origin, that is, hippocampal sclerosis (87,88). The concept of aMCI has been present for a sufficiently long time that many affected patients have progressed to dementia.…”

Emerging Concepts in Alzheimer's Disease

“…Braak stage III and IV AD neuropathologic change was most commonly encountered, but two (of fifteen) patients in one study had neocortical pathologic abnormalities (Braak stage V). Over half of the patients who came to necropsy had evidence of significant CVD, including hippocampal injury that was often interpreted as ischemic in origin, that is, hippocampal sclerosis (87,88). The concept of aMCI has been present for a sufficiently long time that many affected patients have progressed to dementia.…”

Study of brain morphology change in Alzheimer’s disease and amnestic mild cognitive impairment compared with normal controls

“…Dramatic loss of cortical neurons in AD results in severe atrophy of the cerebral grey matter, causing progressive decline in cognition and brain function. Mild cognitive impairment (MCI), a potential precursor to or early form of AD, has the same aetiology, but to a lesser degree 3. Approximately 10 to 15% of patients with MCI experience progression to AD 4 5.…”

“…Mild cognitive impairment (MCI), a potential precursor to or early form of AD, has the same aetiology, but to a lesser degree. 3 Approximately 10 to 15% of patients with MCI experience progression to AD. 4 5 Amnestic MCI (aMCI), a subtype of MCI, is characterised by primary memory deficits, and patients with aMCI have a high risk of progression to AD.…”

Abnormal Changes of Brain Cortical Anatomy and the Association with Plasma MicroRNA107 Level in Amnestic Mild Cognitive Impairment

“…Pathologically, AD is defined by the intracellular accumulation of aggregated and hyperphosphorylated tau protein, the extracellular deposition of amyloid β (Aβ) peptides, and the accumulation of neurofibrillary tangles and amyloid plaques throughout the cortex (De Strooper, 2010 ; Kandimalla et al, 2013a , b ). Amnestic mild cognitive impairment (aMCI) is thought to be a predementia phase of AD (Albert et al, 2011 ), and is characterized by the same etiology to a lesser degree (Petersen et al, 2006 ). A widely accepted hypothesis links the major pathology of AD to the generation and subsequent accumulation of Aβ through sequential cleavage of amyloid precursor protein (APP) by beta-site APP cleaving enzyme 1 (BACE1) 1 and γ-secretase (Dislich and Lichtenthaler, 2012 ).…”

Emerging Concepts in Alzheimer's Disease

“…Braak stage III and IV AD neuropathologic change was most commonly encountered, but two (of fifteen) patients in one study had neocortical pathologic abnormalities (Braak stage V). Over half of the patients who came to necropsy had evidence of significant CVD, including hippocampal injury that was often interpreted as ischemic in origin, that is, hippocampal sclerosis (87,88). The concept of aMCI has been present for a sufficiently long time that many affected patients have progressed to dementia.…”

Study of brain morphology change in Alzheimer’s disease and amnestic mild cognitive impairment compared with normal controls

“…Dramatic loss of cortical neurons in AD results in severe atrophy of the cerebral grey matter, causing progressive decline in cognition and brain function. Mild cognitive impairment (MCI), a potential precursor to or early form of AD, has the same aetiology, but to a lesser degree 3. Approximately 10 to 15% of patients with MCI experience progression to AD 4 5.…”

“…Mild cognitive impairment (MCI), a potential precursor to or early form of AD, has the same aetiology, but to a lesser degree. 3 Approximately 10 to 15% of patients with MCI experience progression to AD. 4 5 Amnestic MCI (aMCI), a subtype of MCI, is characterised by primary memory deficits, and patients with aMCI have a high risk of progression to AD.…”

Abnormal Changes of Brain Cortical Anatomy and the Association with Plasma MicroRNA107 Level in Amnestic Mild Cognitive Impairment

“…Pathologically, AD is defined by the intracellular accumulation of aggregated and hyperphosphorylated tau protein, the extracellular deposition of amyloid β (Aβ) peptides, and the accumulation of neurofibrillary tangles and amyloid plaques throughout the cortex (De Strooper, 2010 ; Kandimalla et al, 2013a , b ). Amnestic mild cognitive impairment (aMCI) is thought to be a predementia phase of AD (Albert et al, 2011 ), and is characterized by the same etiology to a lesser degree (Petersen et al, 2006 ). A widely accepted hypothesis links the major pathology of AD to the generation and subsequent accumulation of Aβ through sequential cleavage of amyloid precursor protein (APP) by beta-site APP cleaving enzyme 1 (BACE1) 1 and γ-secretase (Dislich and Lichtenthaler, 2012 ).…”

Emerging Concepts in Alzheimer's Disease

“…Braak stage III and IV AD neuropathologic change was most commonly encountered, but two (of fifteen) patients in one study had neocortical pathologic abnormalities (Braak stage V). Over half of the patients who came to necropsy had evidence of significant CVD, including hippocampal injury that was often interpreted as ischemic in origin, that is, hippocampal sclerosis (87,88). The concept of aMCI has been present for a sufficiently long time that many affected patients have progressed to dementia.…”

Study of brain morphology change in Alzheimer’s disease and amnestic mild cognitive impairment compared with normal controls

“…Dramatic loss of cortical neurons in AD results in severe atrophy of the cerebral grey matter, causing progressive decline in cognition and brain function. Mild cognitive impairment (MCI), a potential precursor to or early form of AD, has the same aetiology, but to a lesser degree 3. Approximately 10 to 15% of patients with MCI experience progression to AD 4 5.…”

“…Mild cognitive impairment (MCI), a potential precursor to or early form of AD, has the same aetiology, but to a lesser degree. 3 Approximately 10 to 15% of patients with MCI experience progression to AD. 4 5 Amnestic MCI (aMCI), a subtype of MCI, is characterised by primary memory deficits, and patients with aMCI have a high risk of progression to AD.…”

Abnormal Changes of Brain Cortical Anatomy and the Association with Plasma MicroRNA107 Level in Amnestic Mild Cognitive Impairment

“…Pathologically, AD is defined by the intracellular accumulation of aggregated and hyperphosphorylated tau protein, the extracellular deposition of amyloid β (Aβ) peptides, and the accumulation of neurofibrillary tangles and amyloid plaques throughout the cortex (De Strooper, 2010 ; Kandimalla et al, 2013a , b ). Amnestic mild cognitive impairment (aMCI) is thought to be a predementia phase of AD (Albert et al, 2011 ), and is characterized by the same etiology to a lesser degree (Petersen et al, 2006 ). A widely accepted hypothesis links the major pathology of AD to the generation and subsequent accumulation of Aβ through sequential cleavage of amyloid precursor protein (APP) by beta-site APP cleaving enzyme 1 (BACE1) 1 and γ-secretase (Dislich and Lichtenthaler, 2012 ).…”